Role of cyclin A and p27 in anti-IgM-induced G1 growth arrest of murine B-cell lymphomas

Molecular Biology of the Cell

Volumn 7, Issue 4, 1996, Pages 553-564

  Ezhevsky, Sergei A ^a   Toyoshima, Hideo ^b   Hunter, Tony ^b   Scott, David W ^a  

^a HOLLAND LABORATORY   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; IMMUNOGLOBULIN M ANTIBODY; INHIBITOR PROTEIN; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL GROWTH; ENZYME ACTIVITY; ENZYME INHIBITION; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALIA; MURINAE;

EID: 0029940855     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.7.4.553     Document Type: Article

References (67)

1. Akiyama, T., Ohuchi, T., Sumida, S., Matsumoto, K., and Toyoshima, K. (1992). Phosphorylation of the retinoblastoma protein by cdk2. Proc. Natl. Acad. Sci. USA 89, 7900-7904.
2. Aprelikova, O., Xiong, Y., and Liu, E.T. (1995). Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol. Chem. 270, 18195-18197.
3. Benhamou, L.E., Cazenave, P.A., and Sarthou, P. (1990). Anti-immunoglobulins induce death by apoptosis in wehi-231 b lymphoma cells. Eur. J. Immunol. 20, 1405-1407.
4. Buchkovich, K., Duffy, L.A., and Harlow, E. (1989). The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58, 1097-1105.
5. Bui, K.C., Wu, F., Buckley, S., Wu, L., Williams, R., Carbonaro-Hall, D., Hall, F.L., and Warburton, D. (1993). Cyclin A expression in normal and transformed alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 9, 115-125.
6. Bybee, A., and Thomas, N.S. (1992). The synthesis of p58 cyclin A and the phosphorylation of p34 cdc2 are inhibited in human lymphoid cells arrested in G1 by alpha-interferon. Biochim. Biophys. Acta 1137, 73-76.
7. Carbonaro-Hall, D., Williams, R., Wu, L., Warburton, D., Zeichner-David, M., MacDougall, M., Tolo, V., and Hall, F. (1993). G1 expression and multistage dynamics of cyclin A in human osteosarcoma cells. Oncogene 8, 1649-1659.
8. Chen, P.L., Scully, P., Shew, J.Y., Wang, J.Y., and Lee, W.H. (1989). Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58, 1193-1198.
9. Connell-Crowley, L., Solomon, M.J., Wei, N., and Harper, J.W. (1993). Phosphorylation-independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro. Mol. Biol. Cell 4, 79-92.
10. Darbon, J.M., Devault, A., Taviaux, S., Fesquet, D., Martinez, A.M., Galas, S., Cavadore, J.C., Doree, M., and Blanchard, J.M. (1994). Cloning, expression and subcellular localization of the human homolog of p40MO15 catalytic subunit of cdk-activating kinase. Oncogene 9, 3127-3138.
11. DeCaprio, J.A., Ludlow, J.W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C.M., and Livingston, D.M. (1989). The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58, 1085-1095.
12. Dulic, V., Kaufmann, W.K., Wilson, S.J., Tlsty, T.D., Lees, E., Harper, J.W., Elledge, S.J., and Reed, S.I. (1994). p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76, 1013-1023.
13. Durfee, T., Becherer, K., Chen, P.L., Yeh, S.H., Yang, Y., Kilburn, A.E., Lee, W.H., and Elledge, S.J. (1993). The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7, 555-569.
14. Ewen, M.E. (1994). The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev. 13, 45-66.
15. Ewen, M.E., Sluss, H.K., Whitehouse, L.L., and Livingston, D.M. (1993). TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74, 1009-1020.
16. Firpo, E.J., Koff, A., Solomon, M.J., and Roberts, J.M. (1994). Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14, 4889-4901.
17. Fischer, G., Kent, S.C., Joseph, L., Green, D.R., and Scott, D.W. (1994). Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc. J. Exp. Med. 179, 221-228.
18. Girard, F., Strausfeld, U., Fernandez, A., and Lamb, N.J. (1991). Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67, 1169-1179.
19. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261.
20. Harper, J.W., et al. (1995). Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400.
21. Hasbold, J., and Klaus, G.G. (1990). Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur. J. Immu-nol. 20, 1685-1690.
22. Hatakeyama, M., Brill, J.A., Fink, G.R., and Weinberg, R.A. (1994). Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev. 8, 1759-1771.
23. Hinds, P.W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S.I., and Weinberg, R.A. (1992). Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70, 993-1006.
24. Hu, Q.J., Lees, J.A., Buchkovich, K.J., and Harlow, E. (1992). The retinoblastoma protein physically associates with the human cdc2 kinase. Mol. Cell. Biol. 12, 971-980.
25. Hunter, T., and Pines, J. (1994). Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 79, 573-582.
26. Ishida, T., Kobayashi, N., Tojo, T., Ishida, S., Yamamoto, T., and Inoue, J.-C. (1995). CD40 signaling-mediated induction of Bcl-xL, Cdk4, and Cdk6: implication of their cooperation in selective B cell growth. J. Immunol. 155, 5527-5535.
27. Joseph, L.F., Ezhevsky, S.A., and Scott, D.W. (1995). Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1. Cell Growth Differ. 6, 51-58.
28. Kato, J.Y., Matsuoka, M., Polyak, K., Massague, J., and Sherr, C.J. (1994). Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79, 487-496.
29. Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J.W., Elledge, S., Nishimoto, T., Morgan, D.O., Franza, B.R., and Roberts, J.M. (1992). Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257, 1689-1694.
30. Koff, A., Ohtsuki, M., Polyak, K., Roberts, J.M., and Massague, J. (1993). Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science 260, 536-539.
31. La Thangue, N.B. (1994). DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19, 108-114.
32. Lees, E., Faha, B., Dulic, V., Reed, S.I., and Harlow, E. (1992). Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev. 6, 1874-1885.
33. Lees, J.A., Buchkovich, K.J., Marshak, D.R., Anderson, C.W., and Harlow, E. (1991). The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J. 10, 4279-4290.
34. Ludlow, J.W., Glendening, C.L., Livingston, D.M., and DeCaprio, J.A. (1993). Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell. Biol. 13, 367-372.
35. Ludlow, J.W., Shon, J., Pipas, J.M., Livingston, D.M., and DeCaprio, J.A. (1990). The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from sv40 large t. Cell 60, 387-396.
36. Maheswaran, S., McCormack, J.E., and Sonenshein, G.E. (1991). Changes in phosphorylation of myc oncogene and RB anti-oncogene protein products during growth arrest of the murine lymphoma WEHI 231 cell line. Oncogene 6, 1965-1971.
37. Matsushime, H., Ewen, M.E., Strom, D.K., Kato, J.Y., Hanks, S.K., Roussel, M.F., and Sherr, C.J. (1992). Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71, 323-334.
38. Meyerson, M., and Harlow, E. (1994). Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14, 2077-2086.
39. Mihara, K., Cao, X.R., Yen, A., Chandler, S., Driscoll, B., Murphree, A.L., T'Ang, A., and Fung, Y.K. (1989). Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246, 1300-1303.
40. Mittnacht, S., and Weinberg, R.A. (1991). G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65, 381-393.
41. Nourse, J., Firpo, E., Flanagan, W.M., Coats, S., Polyak, K., Lee, M.H., Massague, J., Crabtree, G.R., and Roberts, J.M. (1994). Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570-573.
42. Pagano, M., Pepperkok, R., Lukas, J., Baldin, V., Ansorge, W., Bartek, J., and Draetta, G. (1993). Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J. Cell Biol. 121, 101-111.
43. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., and Draetta, G. (1992). Cyclin A is required at two points in the human cell cycle. EMBO J. 32, 961-971.
44. Pagano, M., Tam, S.W., Thedoras, A.M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P.R., Draetta, G.F., and Rolfe, M. (1995). Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685.
45. 1 phase restriction point. Mol. Cell. Biol. 10, 3003-3012.
46. Pines, J., and Hunter, T. (1992). Cyclins A and B1 in the human cell cycle. Ciba Found. Symp. 170, 187-196.
47. Polyak, K., Kato, J.Y., Solomon, M.J., Sherr, C.J., Massague, J., Roberts, J.M., and Koff, A. (1994a). p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
48. Polyak, K., Lee, M.H., Erdjument-Bromage, H., Koff, A., Roberts, J.M., Tempst, P., and Massague, J. (1994b). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
49. Poon, R.Y.C., Toyoshima, H., and Hunter, T. (1995). Redistribution of the CDK inhibitor p27 between different cyclin CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or UV irradiation. Mol. Biol. Cell 6, 1197-1213.
50. Poon, R.Y.C., Yamashita, K., Howell, M., Ershler, M.A., Belyavsky, A., and Hunt, T. (1994). Cell cycle regulation of the p34cdc2/ p33Cdk2-activating kinase p40MO15. J Cell Sci. 107, 2789-2799.
51. Kip1. Mol. Cell. Biol. 15, 4347-4352.
52. Reynisdottir, I., Polyak, K., Iavarone, A., and Massague, J. (1995). Kip/Cip and Ink4: Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9, 1831-1845.
53. Rosenblatt, J., Gu, Y., and Morgan, D.O. (1992). Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc. Natl. Acad. Sci. USA 89, 2824-2828.
54. Scott, D.W. (1993). Analysis of B cell tolerance in vitro. Adv. Immunol. 54, 393-425.
55. Scott, D.W., Ezhevsky, S., Maddox, B., Washart, K., Yao, X.-R., and Shi, Y. (1995). Scenes from a short life: checkpoints and progression signals for immature B-cell life versus apoptosis. In: Lymphocyte Signalling, ed. K. Rigley and M. Harnett, Chichester, UK: John Wiley.
56. Scott, D.W., Livnat, D., Pennell, C.A., and Keng, P. (1986). Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu. J. Exp. Med. 164, 156-164.
57. Scott, D.W., Livnat, D., Whitin, J., Dillon, S.B., Snyderman, R., and Pennell, C.A. (1987). Lymphoma models for B cell activation and tolerance. V. Anti-Ig-mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium. J. Mol. Cell. Immunol. 3, 109-120.
58. Sherr, C.J. (1994). G1 phase progression: cycling on cue. Cell 79, 551-555.
59. Tanguay, D.A., and Chiles, T.C. (1994). Cell cycle-specific induction of Cdk2 expression in B lymphocytes following antigen receptor cross-linking. Mol. Immunol. 31, 643-649.
60. Templeton, D.J. (1992). Nuclear binding of purified retinoblastoma gene product is determined by cell cycle-regulated phosphorylation. Mol. Cell. Biol. 12, 435-443.
61. Toyoshima, H., and Hunter, T. (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74.
62. Tsai, L.H., Lees, E., Faha, B., Harlow, E., and Riabowol, K. (1993). The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 8, 1593-1602.
63. van den Heuvel, S., and Harlow, E. (1993). Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262, 2050-2054.
64. Warner, G.L., Ludlow, J.W., Nelson, D.A., Gaur, A., and Scott, D.W. (1992). Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent. Cell Growth Differ. 3, 175-181.
65. Yasuda, H., Iguchi, M., Kamijo, M., Honda, R., Nakata, T., and Ohba, Y. (1993). A novel p38cdk (cdk′) reacted with PSTAIR antibody which came from the alternative splicing of cdk2 gene. In: Abstracts of the XIIIth Washington International Spring Symposium: The cell cycle '93: regulators, targets and clinical applications, 1993, Washington, D.C. (Abstract 95).
66. Zhang, H., Hannon, G.J., and Beach, D. (1994). p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8, 1570-1578.
67. Zindy, F., Lamas, E., Chenivesse, X., Sobczak, J., Wang, J., Fesquet, D., Henglein, B., and Brechot, C. (1992). Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun. 182, 1144-1154.